File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/978-3-319-56148-6_9
- Scopus: eid_2-s2.0-85018690286
- WOS: WOS:000426117800009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Conference Paper: Predicting Comprehensive Drug-Drug Interactions for New Drugs via Triple Matrix Factorization
Title | Predicting Comprehensive Drug-Drug Interactions for New Drugs via Triple Matrix Factorization |
---|---|
Authors | |
Keywords | Drug-drug interaction Side effects Matrix Factorization Prediction Regression |
Issue Date | 2017 |
Publisher | Springer. |
Citation | The 5th International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2017), Granada, Spain, 26-28 April 2017. In Rojas, I & Ortuño, F (Eds.). Bioinformatics and Biomedical Engineering. IWBBIO 2017, p. 108-117. Cham: Springer, 2017 How to Cite? |
Abstract | There is an urgent need to discover or deduce drug-drug interactions (DDIs), which would cause serious adverse drug reactions. However, preclinical detection of DDIs bears a high cost. Machine learning-based computational approaches can be the assistance of experimental approaches. Utilizing pre-market drug properties (e.g. side effects), they are able to predict DDIs on a large scale before drugs enter the market. However, none of them can predict comprehensive DDIs, including enhancive and degressive DDIs, though it is important to know whether the interaction increases or decreases the behavior of the interacting drugs before making a co-prescription. Furthermore, existing computational approaches focus on predicting DDIs for new drugs that have none of existing interactions. However, none of them can predict DDIs among those new drugs. To address these issues, we first build a comprehensive dataset of DDIs, which contains both enhancive and degressive DDIs, and the side effects of the involving drugs in DDIs. Then we propose an algorithm of Triple Matrix Factorization and design a Unified Framework of DDI prediction based on it (TMFUF). The proposed approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. Moreover, it provides a unified solution for the scenario that predicting potential DDIs for newly given drugs (having no known interaction at all), as well as the scenario that predicting potential DDIs among these new drugs. Finally, the experiments demonstrate that TMFUF is significantly superior to three state-of-the-art approaches in the conventional binary DDI prediction and also shows an acceptable performance in the comprehensive DDI prediction. |
Persistent Identifier | http://hdl.handle.net/10722/246605 |
ISBN | |
ISSN | 2023 SCImago Journal Rankings: 0.606 |
ISI Accession Number ID | |
Series/Report no. | Lecture Notes in Computer Science book series (LNCS, volume 10208) |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shi, J | - |
dc.contributor.author | Huang, H | - |
dc.contributor.author | Li, JX | - |
dc.contributor.author | Li, P | - |
dc.contributor.author | Zhang, YN | - |
dc.contributor.author | Yiu, SM | - |
dc.date.accessioned | 2017-09-18T02:31:26Z | - |
dc.date.available | 2017-09-18T02:31:26Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | The 5th International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2017), Granada, Spain, 26-28 April 2017. In Rojas, I & Ortuño, F (Eds.). Bioinformatics and Biomedical Engineering. IWBBIO 2017, p. 108-117. Cham: Springer, 2017 | - |
dc.identifier.isbn | 978-3-319-56147-9 | - |
dc.identifier.issn | 0302-9743 | - |
dc.identifier.uri | http://hdl.handle.net/10722/246605 | - |
dc.description.abstract | There is an urgent need to discover or deduce drug-drug interactions (DDIs), which would cause serious adverse drug reactions. However, preclinical detection of DDIs bears a high cost. Machine learning-based computational approaches can be the assistance of experimental approaches. Utilizing pre-market drug properties (e.g. side effects), they are able to predict DDIs on a large scale before drugs enter the market. However, none of them can predict comprehensive DDIs, including enhancive and degressive DDIs, though it is important to know whether the interaction increases or decreases the behavior of the interacting drugs before making a co-prescription. Furthermore, existing computational approaches focus on predicting DDIs for new drugs that have none of existing interactions. However, none of them can predict DDIs among those new drugs. To address these issues, we first build a comprehensive dataset of DDIs, which contains both enhancive and degressive DDIs, and the side effects of the involving drugs in DDIs. Then we propose an algorithm of Triple Matrix Factorization and design a Unified Framework of DDI prediction based on it (TMFUF). The proposed approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. Moreover, it provides a unified solution for the scenario that predicting potential DDIs for newly given drugs (having no known interaction at all), as well as the scenario that predicting potential DDIs among these new drugs. Finally, the experiments demonstrate that TMFUF is significantly superior to three state-of-the-art approaches in the conventional binary DDI prediction and also shows an acceptable performance in the comprehensive DDI prediction. | - |
dc.language | eng | - |
dc.publisher | Springer. | - |
dc.relation.ispartof | Bioinformatics and Biomedical Engineering. IWBBIO 2017 | - |
dc.relation.ispartofseries | Lecture Notes in Computer Science book series (LNCS, volume 10208) | - |
dc.rights | The final publication is available at Springer via http://dx.doi.org/[insert DOI] | - |
dc.subject | Drug-drug interaction | - |
dc.subject | Side effects | - |
dc.subject | Matrix Factorization | - |
dc.subject | Prediction | - |
dc.subject | Regression | - |
dc.title | Predicting Comprehensive Drug-Drug Interactions for New Drugs via Triple Matrix Factorization | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Yiu, SM: smyiu@cs.hku.hk | - |
dc.identifier.authority | Yiu, SM=rp00207 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1007/978-3-319-56148-6_9 | - |
dc.identifier.scopus | eid_2-s2.0-85018690286 | - |
dc.identifier.hkuros | 276754 | - |
dc.identifier.spage | 108 | - |
dc.identifier.epage | 117 | - |
dc.identifier.eissn | 1611-3349 | - |
dc.identifier.isi | WOS:000426117800009 | - |
dc.publisher.place | Cham | - |
dc.identifier.issnl | 0302-9743 | - |